PMID: 8938252Feb 9, 1996Paper

Inhibition of potassium currents by the antiarrhythmic drug E4031 in rat taste receptor cells

Neuroscience Letters
X D Sun, M S Herness

Abstract

The effect of the class III antiarrhythmic agent E4031 was investigated on a non-cardiac preparation as a potential tool for studying potassium currents. Patch clamp recordings in the whole cell configuration were performed on dissociated rat taste cells. These cells possess a variety of potassium currents; they also conduct action potentials. Unlike its more specific action on a type of delayed rectifier channel in cardiac cells, three types of potassium currents were reversibly diminished in taste cells in the presence of E4031. These included transient, sustained, and inwardly-rectifying potassium currents. Activation properties were not altered but the inactivation curve was shifted to the left by approximately 10 mV. Inhibitions of whole cell currents were voltage-dependent, larger at depolarized potentials, but were never complete. E4031 significantly broadened the gustatory action potential and, at higher concentrations, inhibited spike height, suggesting an additional inhibitory effect on sodium channels that was evident in voltage-clamp records. We conclude that E4031 is an effective inhibitor of potassium currents in the micromolar range and that it likely acts at a conserved segment of the potassium channel.

References

Oct 1, 1990·The Journal of General Physiology·K Sugimoto, J H Teeter
Jan 1, 1987·The Journal of Membrane Biology·P Avenet, B Lindemann
Mar 1, 1988·The Journal of General Physiology·S C Kinnamon, S D Roper
Jul 1, 1989·The Journal of Membrane Biology·S D Roper, D W McBride
Nov 20, 1989·Neuroscience Letters·M S Herness
Jul 1, 1995·The Journal of Membrane Biology·M S Herness, X D Sun
Jun 1, 1995·Current Opinion in Neurobiology·C A DoupnikH A Lester
Dec 1, 1994·Journal of Cardiovascular Electrophysiology·Y LiuM Delmar
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M D VarnumJ P Adelman
Jul 1, 1993·The Journal of General Physiology·A Bigiani, S D Roper

❮ Previous
Next ❯

Citations

Aug 24, 1999·British Journal of Pharmacology·H MevesI Wulfsen
Jan 11, 2003·British Journal of Pharmacology·Guido Gessner, Stefan H Heinemann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.